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We report here an extremely rare case of breast signet-ring cell carcinoma (SRCC) initially manifesting as
duodenal metastasis and acute pancreatitis. A 62-year-old female presented with duodenal obstruction and
swollen head of the pancreas, and the diagnosis of acute pancreatitis was initially made. Upper gastroin-
testinal endoscopy revealed duodenal stenosis with erosive mucosa, with signet-ring cells infiltrating the
submucosal layer, suggesting duodenal metastasis of SRCC. Despite absence of a palpable mass in both
breasts, computed tomography revealed diffuse enhancement of the left breast in addition to left axillary
lymphadenopathy. Histological examination of mammary needle biopsy samples revealed SRCC with a non-
invasive lobular carcinoma component. Primary breast SRCC with duodenal metastasis was therefore
diagnosed. The patient underwent palliative surgery twice for intestinal obstruction due to peritoneal
dissemination. She has remained alive without bowel obstruction for 18 months while being treated with
cytotoxic chemotherapies. [Asian J Surg 2007;30(3):220–3]
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Introduction
Signet-ring cell carcinoma (SRCC) can arise from various
intra- and extra-abdominal organs. However, primary breast
SRCC is rare, as is clinically diagnosed gastrointestinal (GI)
metastasis from breast cancer. Most GI metastases from
breast cancer occur as a part of systemic dissemination with
multiple organ metastases, and such GI metastases are not
rare in breast cancer autopsy cases.1 However, there are few
reports of symptoms of GI metastasis as an initial clinical
sign of breast cancer.2,3
We report here an extremely rare case of non-palpable
breast SRCC initially manifesting as duodenal obstruction
and acute pancreatitis due to duodenal metastasis.
Case report
A 62-year-old female was admitted with postprandial 
nausea and vomiting of food residue over a 2-week period.
Upper GI radiography, using water-soluble contrast
medium, revealed obstruction of the descending portion
of the duodenum. Abdominal computed tomography
(CT) revealed a dilated pancreatic duct, swollen pancreatic
head, and thick duodenal wall (Figure 1). Both plasma
and uric amylase levels were high, suggestive of acute pan-
creatitis with duodenal obstruction. Upper GI endoscopy
revealed stenosis of the duodenum with erosive mucosa.
Biopsy samples obtained from the region of stenosis
revealed signet-ring cells infiltrating the submucosal layer
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with an intact mucosa (Figure 2), suggesting duodenal
metastasis of SRCC. Thereafter, to detect the primary
lesion, neck and chest CT was performed and revealed dif-
fuse enhancement of the left breast relative to the right, left
axillary lymphadenopathy, and an osteolytic lesion in a
thoracic vertebra, suggesting bone metastasis. No mass was
palpated nor was any detected by ultrasound examination
in the left breast. Mammography revealed architectural
distortion in the outer part of the left breast. Mammary
needle biopsy blindly aimed at the lesion revealed infiltra-
tion of SRCC with a noninvasive lobular carcinoma compo-
nent (Figure 3). Immunohistochemically, ER/PR status,
human epidermal growth factor receptor-2, and E-cadherin
were negative in duodenal and breast biopsy specimens.
Based on the histological and immunohistochemical simi-
larities between the breast and duodenal lesions, primary
SRCC of the left breast with bone and duodenal meta-
stases was diagnosed.
At laparotomy, a 2-cm mass was found in the second
portion of the duodenum. The pancreas was firm and
swollen, indicating the presence of pancreatitis. Numerous
small white nodules were noted in the peritoneum, indicat-
ing peritoneal carcinomatosis. Based on the presence of
extensive dissemination, we performed gastrojejunostomy
for palliation. Two weeks later, cytotoxic chemotherapy
with paclitaxel was started. However, intestinal obstruc-
tion developed 2 months after the initiation of chemother-
apy due to peritoneal dissemination, suggesting lack of
favorable response to paclitaxel. Laparotomy was per-
formed again, and partial resection of the ileum and trans-
verse colostomy were performed for obstruction of the
ileum and descending colon due to disease dissemination.
Thereafter, anthracycline-based chemotherapy followed
by docetaxel was initiated and is currently being contin-
ued. Two months after initiation of this chemotherapy,
CT revealed that the swollen pancreatic head had normal-
ized in size. The patient has remained alive without bowel
obstruction for 18 months since first admission.
Discussion
Breast SRCC is a rare, aggressive variant that can originate
from both invasive ductal and invasive lobular carcinoma
(ILC).4 In the present case, the presence of a noninvasive
lobular carcinoma component indicated ILC as the origin
of the SRCC, and enabled primary breast SRCC to be dis-
tinguished from metastasis of the breast from other
organs. Clinicopathological differences between lobular
and ductal carcinomas have been documented, including
multicentricity and bilaterality in lobular carcinoma.5
Among such differences, GI metastasis tends to occur with
ILC.6 In addition, SRCC exhibits a propensity to involve the
GI tract.7 Most GI metastases have been found at recurrence
or at autopsy.1 There have been few reports of GI manifes-
tations preceding the diagnosis of breast cancer,2 particu-
larly for duodenal metastasis.3 Acute pancreatitis induced
by metastasis from lung or gastric cancer has been
reported.8 This is the first case, to our knowledge, of acute
pancreatitis induced by breast cancer metastasis.
The mechanisms of induction of acute pancreatitis 
by metastasis include pancreatic ductal obstruction by
metastatic tumour in the pancreas or peripancreatic lymph
Figure 1. Abdominal computed tomography shows a swollen
pancreas head (white arrow) and thick duodenal wall 
(arrowhead).
Figure 2. Histological examination of the duodenal biopsy spec-
imen shows cancer cells infiltrating the submucosal layer with an
intact mucosa; most of the cancer cells are signet-ring cells.
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nodes and vascular compromise by neoplastic destruction
of pancreatic vessels.8 In the present case, obstruction of
the pancreatic duct by diffuse metastasis in the duodenal
wall could have caused acute pancreatitis.
Diagnosis of GI metastasis from breast cancer is some-
times difficult prior to surgical intervention, and primary
GI carcinoma may mistakenly be diagnosed.6,7 In GI meta-
stases, the infiltrating tumour cells are located in the sub-
mucosal layer or deeper with minimal mucosal lesions.6,7
Because findings of diagnostic imaging are frequently not
specific for GI metastasis, GI endoscopy with deep biopsy
is recommended for accurate diagnosis.6 In the present
case, although neither physical nor ultrasound examina-
tion detected abnormalities in the breasts, breast biopsy
was performed due to abnormal enhancement on CT in
the affected breast, and histopathological and immuno-
histochemical comparison of findings enabled the diagno-
sis of breast SRCC with duodenal metastasis. Radiological
modalities including CT and ultrasound may not detect
ILC.9 It is thus important to be aware of breast cancer as 
a possible origin of GI metastases.
For GI metastasis of breast cancer, systemic treatment
is the main form of primary therapy, since this condition
is frequently associated with widespread metastases.
Surgical intervention does not extend patient survival,
but can be considered in patients with bowel obstruction
or bleeding.6 In our case, despite the presence of wide-
spread metastases, multiple palliative surgeries were per-
formed for duodenal and large intestinal obstruction,
resulting in maintenance of oral intake without bowel
obstruction. Because cytotoxic chemotherapy is not
always a promising mode of treatment, surgical interven-
tion may, in selected patients, yield a better outcome than
chemotherapy alone.10
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